To address the national shortage of surgical oncology clinician-investigators, the Department of Surgical Oncology at the University of Texas M. D. Anderson Cancer Center has dedicated its T32 training program to producing academic surgical oncologists. This goal is being met by developing in our T32 trainees the research background skills necessary to be a productive surgical investigator. Moreover, we are committed to providing T32 training to groups that are underrepresented in academic surgical oncology, including minority individuals and women. Our T32 program provides research opportunities in a broad range of basic oncologic disciplines, including tumor biology, oncogene and tumor suppressor gene biology, signal therapeutics and other cancer-related research areas. In addition, we recently reincorporated the option for T32 fellows to obtain training in """"""""clinical effectiveness"""""""" while still obtaining didactic training in basic science research. This training broadens the education of all trainees through our conference structure. This versatility in academic training increases the likelihood of obtaining an academic position upon completion of training. Training in biostatistics and the responsible conduct of research, and a rich array of seminars and graduate courses are integral to this T32 program. Training is offered to postdoctoral M.D. fellows either during a 24-month hiatus from General Surgery residency or during a two to three-year fellowship in Surgical Oncology that begins after General Surgery residency. Upon completion of training almost all (94%) T32 trainees have either entered Surgical Oncology fellowships or geographic full time academic Surgical Oncology positions. The T32 program faculty includes surgical investigators and full-time academic basic science researchers, all of whom have peer-reviewed grant support. The University of Texas M. D. Anderson Cancer Center vigorously promulgates a core mission excellence in research, education, and patient care. As a result, this is a highly stimulating environment in which aspiring academic surgical oncologists can receive research training under the aegis of the T32 program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009599-24
Application #
8214580
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1994-05-25
Project End
2013-03-31
Budget Start
2012-02-01
Budget End
2013-03-31
Support Year
24
Fiscal Year
2012
Total Cost
$350,884
Indirect Cost
$37,749
Name
University of Texas MD Anderson Cancer Center
Department
Surgery
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Kim, Bradford J; Aloia, Thomas A (2018) What Is ""Enhanced Recovery,"" and How Can I Do It? J Gastrointest Surg 22:164-171
Keung, Emily Z; Lazar, Alexander J; Torres, Keila E et al. (2018) Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18:913
Khong, Hiep; Volmari, Annika; Sharma, Meenu et al. (2018) Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response. J Immunol 200:3464-3474
Wang, Yinghong; Wiesnoski, Diana H; Helmink, Beth A et al. (2018) Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med :
Helmink, Beth A; Gaudreau, Pierre-Olivier; Wargo, Jennifer A (2018) Immune Checkpoint Blockade across the Cancer Care Continuum. Immunity 48:1077-1080
Keung, Emily Z; Ikoma, Naruhiko; Benjamin, Robert et al. (2018) The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 117:1799-1805
Koay, Eugene J; Lee, Yeonju; Cristini, Vittorio et al. (2018) A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24:5883-5894
Keung, Emily Z; Tsai, Jen-Wei; Ali, Ali M et al. (2018) Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7:e1385689
Keung, Emily Z; Chiang, Yi-Ju; Cormier, Janice N et al. (2018) Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124:4495-4503
Narula, Nisha; Kim, Bradford J; Davis, Catherine H et al. (2018) A proactive outreach intervention that decreases readmission after hepatectomy. Surgery 163:703-708

Showing the most recent 10 out of 202 publications